CA
Continental Advisors Portfolio holdings
AUM
$140M
This Quarter Return
-0.54%
1 Year Return
+10.45%
3 Year Return
+26.28%
5 Year Return
+49.35%
10 Year Return
+58.99%
AUM
$111M
AUM Growth
+$111M
(-2.2%)
Cap. Flow
-$979K
Cap. Flow
% of AUM
-0.88%
Top 10 Holdings %
Top 10 Hldgs %
53.22%
Holding
42
New
–
Increased
11
Reduced
16
Closed
3
Top Buys
| 1 |
Pfizer
PFE
|
$1.84M |
| 2 |
Federated Hermes
FHI
|
$1.58M |
| 3 |
Northern Trust
NTRS
|
$1.45M |
| 4 |
Western Union
WU
|
$922K |
| 5 |
Capital One
COF
|
$776K |
Top Sells
| 1 |
SCU
Sculptor Capital Management, Inc. Class A Common Stock
SCU
|
$2.01M |
| 2 |
iShares Core MSCI Emerging Markets ETF
IEMG
|
$857K |
| 3 |
Teva Pharmaceuticals
TEVA
|
$740K |
| 4 |
Alerian MLP ETF
AMLP
|
$675K |
| 5 |
Viatris
VTRS
|
$587K |
Sector Composition
| 1 | Financials | 36.51% |
| 2 | Healthcare | 31.11% |
| 3 | Technology | 9.31% |
| 4 | Consumer Discretionary | 3.76% |
| 5 | Energy | 3% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Uber
UBER
$196B
| $10.3M | 5.49% |
224,148
+1,776
| +0.8% | +$81.7K |
|
|
2
Pfizer
PFE
$141B
| $8.3M | 4.42% |
250,292
+55,600
| +29% | +$1.84M |
|
|
3
Viatris
VTRS
$12.3B
| $6.23M | 3.32% |
631,389
-59,500
| -9% | -$587K |
|
4
Gilead Sciences
GILD
$140B
| $6.14M | 3.27% |
81,903
| – | – |
|
|
5
Capital One
COF
$145B
| $6.1M | 3.25% |
62,810
+8,000
| +15% | +$776K |
|
6
Invesco
IVZ
$9.76B
| $4.78M | 2.55% |
329,071
-24,000
| -7% | -$348K |
|
|
7
Western Union
WU
$2.8B
| $4.73M | 2.52% |
359,090
+69,929
| +24% | +$922K |
|
8
Cannae Holdings
CNNE
$1.09B
| $4.17M | 2.22% |
223,535
+4,576
| +2% | +$85.3K |
|
|
9
Alerian MLP ETF
AMLP
$10.7B
| $4.15M | 2.21% |
98,223
-16,000
| -14% | -$675K |
|
10
Perrigo
PRGO
$3.27B
| $4.02M | 2.14% |
125,778
-12,000
| -9% | -$383K |
|
11
Energy Select Sector SPDR Fund
XLE
$27.6B
| $3.89M | 2.07% |
43,000
-1,000
| -2% | -$90.4K |
|
12
Cardinal Health
CAH
$35.5B
| $3.7M | 1.97% |
42,584
| – | – |
|
|
13
Teva Pharmaceuticals
TEVA
$21.1B
| $3.48M | 1.85% |
340,866
-72,500
| -18% | -$740K |
|
14
Wells Fargo
WFC
$263B
| $3.45M | 1.84% |
84,406
+4,004
| +5% | +$164K |
|
15
Shell
SHEL
$215B
| $3.32M | 1.77% |
51,520
-3,500
| -6% | -$225K |
|
16
iShares MSCI Singapore ETF
EWS
$792M
| $3.02M | 1.61% |
164,774
-10,000
| -6% | -$184K |
|
17
Goldman Sachs
GS
$226B
| $3.01M | 1.6% |
9,293
| – | – |
|
|
18
Federated Hermes
FHI
$4.12B
| $2.93M | 1.56% |
86,542
+46,662
| +117% | +$1.58M |
|
19
Truist Financial
TFC
$60.4B
| $2.85M | 1.52% |
99,450
+2,000
| +2% | +$57.2K |
|
20
SPDR S&P Biotech ETF
XBI
$5.07B
| $2.72M | 1.45% |
37,200
+1,500
| +4% | +$110K |
|
21
Brookdale Senior Living
BKD
$1.83B
| $2.4M | 1.28% |
579,989
-29,351
| -5% | -$122K |
|
22
JPMorgan Chase
JPM
$829B
| $2.27M | 1.21% |
15,635
-1,000
| -6% | -$145K |
|
|
B
23
Barrick Mining Corporation
B
$45.4B
| $2.11M | 1.13% |
145,267
| – | – |
|
24
Citigroup
C
$178B
| $2.03M | 1.08% |
49,434
-3,848
| -7% | -$158K |
|
|
25
iShares Core MSCI Emerging Markets ETF
IEMG
$102B
| $1.82M | 0.97% |
38,300
-18,000
| -32% | -$857K |
|